Inventor
JAMES GAIL CHRISTENSEN
Inventor
US
Overview
Patents· 15 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations38%
A61KPreparations for medical, dental or toiletry purposes35%
C07DHeterocyclic compounds20%
C07KPeptides5%
H05KPrinted circuits3%
PatentTitleYear
12,527,795Compositions of adagrasib and mTOR inhibitors and methods of treatment therewith202612,485,122Combination of palbociclib and adagrasib for lung cancer202512,377,101Combination therapies202512,371,435Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors202512,336,995Combination therapies202512,208,099Combination therapies202512,171,765Combination therapies using PRMT5 inhibitors for the treatment of cancer202412,128,048Combination therapies using PRMT5 inhibitors for the treatment of cancer202411,964,989KRas G12D inhibitors202411,890,285Combination therapies202411,548,888KRas G12C inhibitors202311,485,738Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors202211,453,683KRas G12D inhibitors202211,267,812KRAS G12C inhibitors202211,220,509Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to MIRATI THERAPEUTICS INC (15)· patent assignee history
2022–2024Patents assigned to ARRAY BIOPHARMA INC (4)· patent assignee history
2022–2026Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MIRATI THERAPEUTICS INC | 15 | 2022–2026 |
| ARRAY BIOPHARMA INC | 4 | 2022–2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 15 | 2022–2026 |